NSE · NH · Healthcare
Narayana Hrudayalaya Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹1,185 Cr with net profit ₹176 Cr — a 14.82% net margin, versus 12.57% the period before.
Shareholding
As of 2026-09-30
- Promoter63.27%
- Public17.04%
- FII9.01%
- DII10.68%
1,98,623 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.32× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #6 of 87 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,21,441 Cr | 53.63 | 11.45 | 21.14% | 8.12% |
| Max Healthcare Institute Ltd. | ₹90,909 Cr | 64.02 | 8.02 | 12.18% | 15.1% |
| Manipal Health Enterpri Limited | ₹85,065 Cr | 90.7 | 5.18 | 10.59% | 7.81% |
| Aster DM Quality Care Ltd. | ₹62,142 Cr | 160.2 | 14.77 | 8.48% | 6.54% |
| Fortis Healthcare Ltd. | ₹57,898 Cr | 54.27 | 5.53 | 9.91% | 10.48% |
| Narayana Hrudayalaya Ltd.(this company) | ₹38,890 Cr | 42.98 | 7.77 | 17.17% | 8.36% |
| Global Health Limited | ₹37,309 Cr | 57.62 | 8.63 | 14.3% | 12.24% |
| Dr. Lal Path Labs Ltd. | ₹33,066 Cr | 54.59 | 12.03 | 21.32% | 19.29% |
| Krishna Institute of Medical Sciences Ltd. | ₹30,366 Cr | 149.38 | 7.72 | 5.4% | 4.62% |
| Dr. Agarwal's Health Care Limited | ₹16,371 Cr | 111.04 | 7.32 | 8.04% | 7.61% |
AI analysis
AI-generated · google/gemini-2.5-flashNarayana Hrudayalaya Ltd. operates in the Healthcare sector. The company has a market capitalisation of Rs 40825 Cr. As of Mar 2025, its annual revenue was Rs 5575.012 Cr, with a net profit of Rs 790.155 Cr. The Earnings Per Share (EPS) as of Mar 2025 was Rs 38.9, while the latest reported EPS is Rs 41.68.
Positives
- +The profit margin is 10.2%.
- +Return on Equity (ROE) is 17.76%.
- +Promoter holding of 63.2747% as of June 30, 2026 is high.
- +Promoter pledge is 0%, indicating no shares are pledged.
Negatives
- −The trailing PE ratio of 181.28 is high relative to its EPS of Rs 41.68.
- −The dividend yield is 23%, which may be unsustainable.
- −Quarterly results are not disclosed since Mar 2026.
Financial performance
Narayana Hrudayalaya Ltd. reported an annual revenue of Rs 5575.012 Cr in Mar 2025, and a net profit of Rs 790.155 Cr. Quarterly revenue for Mar 2026 was Rs 2593.81 Cr, representing a growth of 12.12%. Net profit for the same quarter was Rs 223.88 Cr.
Profitability & Returns
The company's profit margin stood at 10.2%. Return on Equity (ROE) was 17.76%, and Return on Capital Employed (ROCE) was 11.4186%. The diluted EPS is Rs 41.68 with a PE ratio of 181.28.
Balance Sheet
The company has a Book Value of Rs 222.02. The debt-to-equity ratio is 0.62, indicating its leverage. No further details on assets or liabilities are available from the provided data.
Ownership & Pledges
Public shareholding is 18.2684%, with institutional holding at 18.4569%. There is no promoter pledge reported.
Regulatory & Surveillance
No information regarding any regulatory actions or inclusion on a surveillance list has been provided for Narayana Hrudayalaya Ltd. This suggests the company is not currently under specific regulatory scrutiny based on the available data.
Data as of — price: 2026-11-07 · financials: Sep 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.